Vanda Pharmaceuticals Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vanda Pharmaceuticals Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Vanda Pharmaceuticals Inc. Debt-to-equity for the quarter ending June 30, 2024 was 19.3 %, a 3.55% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 19.3 -0.71 -3.55% Jun 30, 2024
Q1 2024 19 -1.25 -6.18% Mar 31, 2024
Q4 2023 19.1 -1.15 -5.69% Dec 31, 2023
Q3 2023 19.4 -0.15 -0.77% Sep 30, 2023
Q2 2023 20 +1.22 +6.5% Jun 30, 2023
Q1 2023 20.2 +1.92 +10.5% Mar 31, 2023
Q4 2022 20.2 +2.89 +16.7% Dec 31, 2022
Q3 2022 19.5 +2.21 +12.7% Sep 30, 2022
Q2 2022 18.8 +1.55 +9% Jun 30, 2022
Q1 2022 18.3 +1.25 +7.32% Mar 31, 2022
Q4 2021 17.3 -0.06 -0.35% Dec 31, 2021
Q3 2021 17.3 -0.04 -0.23% Sep 30, 2021
Q2 2021 17.2 -0.45 -2.55% Jun 30, 2021
Q1 2021 17.1 -2.22 -11.5% Mar 31, 2021
Q4 2020 17.4 -3.88 -18.2% Dec 31, 2020
Q3 2020 17.4 -4.9 -22% Sep 30, 2020
Q2 2020 17.7 -5.32 -23.1% Jun 30, 2020
Q1 2020 19.3 -2.42 -11.1% Mar 31, 2020
Q4 2019 21.3 -1.58 -6.92% Dec 31, 2019
Q3 2019 22.3 -6.23 -21.9% Sep 30, 2019
Q2 2019 23 -13.7 -37.4% Jun 30, 2019
Q1 2019 21.7 -26.3 -54.8% Mar 31, 2019
Q4 2018 22.8 -35.7 -61% Dec 31, 2018
Q3 2018 28.5 -31 -52.1% Sep 30, 2018
Q2 2018 36.7 -23.7 -39.2% Jun 30, 2018
Q1 2018 48 -13.8 -22.3% Mar 31, 2018
Q4 2017 58.5 -5.33 -8.35% Dec 31, 2017
Q3 2017 59.5 -4.34 -6.8% Sep 30, 2017
Q2 2017 60.4 -0.48 -0.79% Jun 30, 2017
Q1 2017 61.8 +5.19 +9.17% Mar 31, 2017
Q4 2016 63.8 +14 +28.1% Dec 31, 2016
Q3 2016 63.8 +27.6 +76.2% Sep 30, 2016
Q2 2016 60.9 +12.6 +26.1% Jun 30, 2016
Q1 2016 56.6 -18.1 -24.2% Mar 31, 2016
Q4 2015 49.9 -99.4 -66.6% Dec 31, 2015
Q3 2015 36.2 -505 -93.3% Sep 30, 2015
Q2 2015 48.3 -288 -85.6% Jun 30, 2015
Q1 2015 74.7 -272 -78.4% Mar 31, 2015
Q4 2014 149 -262 -63.7% Dec 31, 2014
Q3 2014 541 -105 -16.3% Sep 30, 2014
Q2 2014 336 -999 -74.8% Jun 30, 2014
Q1 2014 346 -656 -65.4% Mar 31, 2014
Q4 2013 412 -344 -45.6% Dec 31, 2013
Q3 2013 646 +51 +8.57% Sep 30, 2013
Q2 2013 1.33K +832 +166% Jun 30, 2013
Q1 2013 1K +554 +124% Mar 31, 2013
Q4 2012 756 Dec 31, 2012
Q3 2012 595 Sep 30, 2012
Q2 2012 502 Jun 30, 2012
Q1 2012 448 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.